Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

IDEAYA Biosciences, Inc. Common Stock (IDYA)

Pharmaceutical Preparations

https://www.ideayabio.com

IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

7000 SHORELINE COURT, SUITE 350
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/23/2019

Market Cap

3,221,279,595

Shares Outstanding

70,580,000

Weighted SO

69,013,253

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ANAB --.--%

MGTX --.--%

KROS --.--%

FIXX --.--%

VTYX --.--%

PTGX --.--%

VRNA --.--%

SNDX --.--%

CERE --.--%

Beta

0.8600

Last Div

0.0000

Range

23.41-47.735

Chg

0.0200

Avg Vol

1031520

Mkt Cap

3221279595

Exch

NASDAQ

Country

US

Phone

650 443 6209

DCF Diff

38.4542

DCF

-0.3442

Div Yield

0.0000

P/S

269.3152

EV Multiple

-16.0626

P/FV

3.1908

Div Yield %

0.0000

P/E

-19.3361

PEG

-1.0862

Payout

0.0000

Current Ratio

17.5048

Quick Ratio

17.5048

Cash Ratio

4.4929

DSO

0.0305

DIO

0.0000

Op Cycle

0.0305

DPO

1384.1943

CCC

-1384.1638

Gross Margin

0.6498

Op Margin

-16.0008

Pretax Margin

-12.8534

Net Margin

-12.8534

Eff Tax Rate

-0.0229

ROA

-0.1579

ROE

-0.2053

ROCE

-0.2051

NI/EBT

1.0000

EBT/EBIT

0.8033

EBIT/Rev

-16.0008

Debt Ratio

0.0019

D/E

0.0020

LT Debt/Cap

0.0014

Total Debt/Cap

0.0020

Int Coverage

-7.6349

CF/Debt

-69.8860

Equity Multi

1.0451

Rec Turnover

11961.0000

Pay Turnover

0.2637

Inv Turnover

0.0000

FA Turnover

1.4194

Asset Turnover

0.0123

OCF/Share

-1.6754

FCF/Share

-1.7233

Cash/Share

8.9999

OCF/Sales

-10.9202

FCF/OCF

1.0286

CF Coverage

-69.8860

ST Coverage

-215.5396

CapEx Coverage

-34.9337

Div&CapEx Cov

-34.9337

P/BV

3.1908

P/B

3.1908

P/S

269.3152

P/E

-19.3361

P/FCF

-23.9757

P/OCF

-22.7591

P/CF

-22.7591

PEG

-1.0862

P/S

269.3152

EV Multiple

-16.0626

P/FV

3.1908

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 10, 12:01 Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know Benzinga Nov 13, 11:00 The Latest Analyst Ratings for IDEAYA Biosciences

Revenue Product Segmentation